| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
iSpecimen (NASDAQ:ISPC) reported its Q4 earnings results on Wednesday, March 13, 2024 at 05:28 PM.
Here's what investors need to know about the announcement.
iSpecimen missed estimated earnings by -42.0%, reporting an EPS of $-0.34 versus an estimate of $-0.24.
Revenue was down $387 thousand from the same period last year.
Last quarter the company beat on EPS by $0.12 which was followed by a 3.0% drop in the share price the next day.
Here's a look at iSpecimen's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.35 | -0.30 | -0.32 | -0.37 |
| EPS Actual | -0.23 | -0.39 | -0.27 | -0.24 |
| Revenue Estimate | 2.23M | 3.07M | 2.62M | 2.67M |
| Revenue Actual | 2.78M | 1.62M | 2.95M | 2.96M |
To track all earnings releases for iSpecimen visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: ISPC
